Precision BioSciences (Nasdaq: DTIL) has received approval in Hong Kong to begin clinical trials evaluating a gene editing ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Soliwoda-Doan was one of many Americans who had never even heard of H.B.V. There is no cure for hepatitis B, but it is ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, ...

More than 250 million people live with chronic hepatitis B, making it the most common chronic infection worldwide.1 Despite effective tools to prevent transmission, diagnosis, and treatment, hepatitis ...

AusperBio raises $73 million in series B funding to advance Phase II trials of AHB-137, its antisense oligonucleotide therapy ...

Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...

Local Hepatitis Elimination and Prevention Programme (LHEAP) and Gulf Care Hospital (GCH), a large private hospital, have ...

As the Hepatitis B Virus (HBV) spreads across Nigeria, drug merchants are selling untested alternative medicines to patients, ...

Hepatitis D can lead to a host of devastating symptoms and is the most severe form of viral hepatitis. “It's much more ...

As the Hepatitis B Virus (HBV) spreads across Nigeria, drug merchants are selling untested alternative medicines to patients, ...